This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Centor criteria to aid diagnosis of Group A beta-haemolytic streptococcus

Authoring team

Centor criteria to aid diagnosis of Group A beta-haemolytic streptococcus (GABHS)as a cause of presentation with a sore throat:

  • tonsillar exudate
  • tender anterior cervical lymph nodes
  • absence of cough
  • history of fever
  • presence of three or four of these clinical signs suggests that the chance of the patient having GABHS is between 40% and 60%, so the patient may benefit from antibiotic treatment
  • absence of three or four of the signs suggests that there is an 80% chance that the patient doesn't have the infection, and antibiotics are unlikely to be necessary
  • in patients with tonsillitis who are unwell, and have three out of four of these criteria, the risk of quinsy is 1:60 compared with 1:400 in those who are not unwell
  • centor criteria is not ideal, and will lead to some patients with bacterial pharyngitis not being treated and result in unnecessary antibiotic treatment for others

Reference:

  1. MeReC Bulletin 2006;17(3):12-14.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.